MISSISSAUGA, ON, July 25, 2018 /CNW/ - Baxter Canada, a leader in innovative technology for medication delivery, today announced Health Canada approval for the Spectrum IQInfusion System with Dose IQ ...

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.S. Food and Drug Administration (FDA) ...

Baxter International Inc BAX has issued an urgent correction for its Spectrum V8 and Spectrum IQ infusion pumps, applicable in the U.S. and Puerto Rico, due to a ...

Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...

Baxter International Inc. BAX recently announced that it has received the CE marking and regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for the Evo IQ Syringe Infusion ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s ...

Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation Offers Both English and French Language Options and ...

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas Medical Branch (UTMB Health) ...

DEERFIELD, Ill., December 11, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The ...